Detailed Explanation of De Novo Protein Sequencing Steps and Common Misunderstandings
De novo protein sequencing is a method that directly deduces the amino acid sequence of proteins using mass spectrometry without relying on databases. It is widely used in novel protein identification, antibody sequence analysis, and protein post-translational modification (PTM) studies. Although this technique holds great potential in non-model organism research and protein engineering, it still faces numerous challenges in data quality, algorithmic interpretation, and experimental operations. We will now delve into its core steps and analyze common misconceptions in experimental and data analysis processes to help researchers improve their accuracy and efficiency.
I. Core Steps
1. Sample Preparation and Protein Extraction
High-quality sample preparation is a prerequisite for successful de novo protein sequencing. Researchers should choose appropriate lysis methods (such as chemical, enzymatic, or mechanical disruption) based on the characteristics of the target protein to prevent protein degradation or denaturation. Additionally, efficient protein purification methods, such as affinity chromatography or gel electrophoresis, should be used to increase the concentration and purity of the target protein.
2. Protease Digestion and Peptide Preparation
To obtain peptides suitable for mass spectrometry analysis, protein samples usually need to be digested with specific proteases (such as trypsin, Lys-C, Glu-C). Proper selection of digestion conditions (temperature, pH, reaction time) can prevent non-specific cleavage and improve peptide uniformity. Moreover, using multiple proteases for parallel digestion helps increase sequence coverage and reduce peptide omission.
3. Liquid Chromatography-Mass Spectrometry (LC-MS/MS) Analysis
Mass spectrometry is the core tool for de novo sequencing. High-performance liquid chromatography separates peptides, and tandem mass spectrometry (MS/MS) obtains fragment ion data to deduce sequences. Choosing high-resolution mass spectrometers (such as Orbitrap, TOF) and appropriate fragmentation modes (such as HCD, ETD, ECD) can improve data quality and enhance peptide identification capabilities.
4. Data Analysis and Sequence Derivation
After obtaining mass spectrometry data, algorithms (such as PEAKS, Novor, DeepNovo) are used to interpret b/y ion sequences and predict possible amino acid arrangements. Combining graph theory, dynamic programming, and deep learning algorithms to analyze fragment information from multiple angles enhances the accuracy of sequence interpretation.
5. Sequence Assembly and Complete Protein Sequence Construction
Once individual peptides are interpreted, overlapping regions of peptides, isotopic labeling data, etc., are used to assemble a complete protein sequence. Cross-verifying and database comparison with data obtained from different digestion methods help confirm the accuracy of the results.
6. Experimental Validation and Data Quality Control
To ensure the accuracy of the final results, necessary experimental validations such as Edman degradation, synthetic peptide comparison, and isotope labeling (such as SILAC, TMT) should be conducted. Quality control processes, including the removal of low-quality data, optimization of signal-to-noise ratio, and checking peptide coverage, ensure data reliability.
II. Common Misconceptions in De Novo Protein Sequencing
1. Improper Sample Handling Leading to Protein Degradation
During protein extraction and purification, factors such as protease contamination, high temperatures, and pH changes may lead to protein degradation, affecting subsequent mass spectrometry analysis. Researchers should optimize sample preparation processes, such as using protease inhibitors, operating at low temperatures, and minimizing exogenous protein contamination.
2. Single Protease Digestion Strategy Affecting Sequence Coverage
Using only one protease may result in certain regions not being effectively cleaved, affecting the completeness of protein sequence assembly. Therefore, it is recommended to use multiple proteases for cross-digestion to increase sequence coverage.
3. Low Quality of Mass Spectrometry Data Affecting Analysis Accuracy
The signal-to-noise ratio, resolution, and accuracy of mass spectrometry data directly determine the success rate of de novo protein sequencing. Low-quality spectra may lead to mismatches or erroneous sequence derivation. Researchers should ensure appropriate mass spectrometry parameters (such as suitable fragmentation energy, resolution) and perform data denoising to improve signal reliability.
4. Over-Reliance on a Single Algorithm for Data Analysis
Current de novo sequencing algorithms each have their strengths and limitations, and a single algorithm may not be suitable for all types of mass spectrometry data. Researchers should combine multiple methods (such as graph algorithms, dynamic programming, deep learning) for cross-validation and use multi-level filtering strategies to enhance sequence accuracy.
5. Ignoring Experimental Validation Leading to Erroneous Results
Relying solely on mass spectrometry data without experimental validation may lead to erroneous sequence derivation. Edman degradation, isotope labeling, or synthetic peptide validation are key steps to ensure result reliability. Researchers should use multiple validation methods for cross-confirmation.
De novo protein sequencing is a complex yet effective technique that plays a role in new protein discovery, antibody engineering, and post-translational modification research. By optimizing experimental processes, improving data quality, combining multiple algorithms for analysis, and using appropriate experimental validation methods, sequencing accuracy and data analysis efficiency can be significantly improved. BioPark Biotechnology offers high-quality de novo sequencing services, feel free to contact us!
BioPark Biotechnology - Characterization of Biological Products, High-Quality Multi-Omics Mass Spectrometry Services Provider
Related Services:
How to order?
